Technology | October 01, 2014

Intelerad Launches Tomosynthesis Module With Diagnostic Features and Functionality

intelerad, inteleviewer, mammography

A mammography screenshot from Intelerad's InteleViewer

October 1, 2014 — Intelerad Medical Systems launched its new Tomosynthesis Module. Integrated directly into Intelerad’s InteleViewer, the module eliminates the need for dedicated workstations, allowing practices to easily open new revenue streams, while enhancing radiologists’ workflows by allowing them to read tomosynthesis studies from their main workstation. 

“At Intelerad, we’ve built a tradition of developing innovative solutions that provide real value to radiology practices,” said Randall Oka, president and CEO, Intelerad. “Our Tomosynthesis Module is no different, as it provides radiology groups with the easiest way to expand their breast imaging offerings and attract new clients, all while improving radiologists’ productivity.” 

Evolving from Intelerad’s Breast Imaging module, which provided clinical support for tomosynthesis, the Tomosynthesis Module provides radiologists with the diagnostic functionality they need to fully support the modality. Featuring a number of integrated stacking and comparison tools, the module further drives radiologists’ productivity by quickly retrieving tomosynthesis images in their proper orientation, providing automated layout protocols, and allowing images to be stored locally on their workstation. 
 
“From a clinical perspective, the true benefit of our expanded breast imaging capabilities is that it will help increase the detection of lesions,” said Rick Rubin, CEO, Intelerad. “The module also improves report turnaround time by allowing users to interact with both 2-D and 3-D data in a familiar workflow, and allowing them to easily interact with referring physicians and leverage reporting tools that are not commonly found in dedicated workstations.”
 
For more information: www.intelerad.com

Related Content

Simulation finds starting at age 30 with MRI and mammography to be the preferred strategy; starting at 25 prevented marginally more deaths, but with more testing and emotional stress

Getty Images

News | Breast Imaging | July 09, 2020
July 9, 2020 — Chest radiation is used to treat children with Hodgkin and non-Hodgkin lymphoma as well as lung metast
Hologic, Inc. announced he U.S. launch of the SuperSonic MACH 40 ultrasound system, expanding the company’s suite of ultrasound technologies with its first premium, cart-based system.
News | Breast Imaging | July 08, 2020
July 8, 2020 — Hologic, Inc. announced he U.S.
Sponsored Content | Videos | PACS | June 29, 2020
Kevin Borden, Vice President of Product, Healthcare IT for Konica Minolta, talks about Improving Access and Aiding Wo
VolparaEnterprise data analysis shows mammography screening volumes are quickly increasing
News | Mammography | June 09, 2020
June 9, 2020 — More than 75 percent of hospitals and imaging centers that perform mammography across the United State
Developed by medical AI company Lunit, Software detects breast cancer with 97% accuracy; Study in Lancet Digital Health shows that Lunit INSIGHT MMG-aided radiologists showed an increase in sensitivity

Lunit INSIGHT MMG

News | Artificial Intelligence | June 02, 2020
June 2, 2020 — Lunit announced that its artificia...
AI has the potential to help radiologists improve the efficiency and effectiveness of breast cancer imaging

Getty Images

Feature | Breast Imaging | May 28, 2020 | By January Lopez, M.D.
Headlines around the world the past several months declared that...
In April, the U.S. Food and Drug Administration (FDA) cleared Intelerad’s InteleConnect EV solution for diagnostic image review on a range of mobile devices.
Feature | PACS | May 27, 2020 | By Melinda Taschetta-Millane
Fast, easily accessible patient images are crucial in this day and age, as imaging and medical records take on a new
a Schematic of the system. The entire solid tumour is illuminated from four sides by a four-arm fibre bundle. A cylindrically focused linear array is designed to detect optoacoustic signals from the tumour. In vivo imaging is performed in conical scanning geometry by controlling the rotation and translation stages. The sensing part of the transducer array and the tumour are submerged in water to provide acoustic coupling. b Maximum intensity projections of the optoacoustic reconstruction of a phantom of pol

a Schematic of the system. The entire solid tumour is illuminated from four sides by a four-arm fibre bundle. A cylindrically focused linear array is designed to detect optoacoustic signals from the tumour. In vivo imaging is performed in conical scanning geometry by controlling the rotation and translation stages. The sensing part of the transducer array and the tumour are submerged in water to provide acoustic coupling. b Maximum intensity projections of the optoacoustic reconstruction of a phantom of polyethylene microspheres (diameter, 20 μm) dispersed in agar. The inset shows a zoomed-in view of the region boxed with a yellow dashed line. In addition, the yellow boxes are signal profiles along the xy and z axes across the microsphere centre, as well as the corresponding full width at half-maximum values. c Normalized absorption spectra of Hb, HbO2 and gold nanoparticles (AuNPs). The spectrum for the AuNPs was obtained using a USB4000 spectrometer (Ocean Optics, Dunedin, FL, USA), while the spectra for Hb and HbO2 were taken from http://omlc.org/spectra/haemoglobin/index.html. The vertical dashed lines indicate the five wavelengths used to stimulate the three absorbers: 710, 750, 780, 810 and 850 nm. Optoacoustic signals were filtered into a low-frequency band (red) and high-frequency band (green), which were used to reconstruct separate images.

News | Breast Imaging | May 26, 2020
May 26, 2020 — Breast cancer is the most common cancer in women.